170 related articles for article (PubMed ID: 27401155)
1. Anaplastic astrocytoma: prognostic factors and survival in 4807 patients with emphasis on receipt and impact of adjuvant therapy.
Shin JY; Diaz AZ
J Neurooncol; 2016 Sep; 129(3):557-565. PubMed ID: 27401155
[TBL] [Abstract][Full Text] [Related]
2. Utilization and impact of adjuvant therapy in anaplastic oligodendroglioma: an analysis on 1692 patients.
Shin JY; Diaz AZ
J Neurooncol; 2016 Sep; 129(3):567-575. PubMed ID: 27401158
[TBL] [Abstract][Full Text] [Related]
3. Influence of insurance status and income in anaplastic astrocytoma: an analysis of 4325 patients.
Shin JY; Yoon JK; Diaz AZ
J Neurooncol; 2017 Mar; 132(1):89-98. PubMed ID: 27864706
[TBL] [Abstract][Full Text] [Related]
4. Gliosarcoma in septuagenarians and octogenarians: What is the impact of adjuvant chemoradiation?
Shin JY; Yoon JK; Diaz AZ
J Clin Neurosci; 2017 Nov; 45():77-82. PubMed ID: 28756069
[TBL] [Abstract][Full Text] [Related]
5. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population.
Rusthoven CG; Carlson JA; Waxweiler TV; Dally MJ; Barón AE; Yeh N; Gaspar LE; Liu AK; Ney DE; Damek DM; Lillehei KO; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):894-902. PubMed ID: 25585784
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities in anaplastic oligodendroglioma: An analysis on 1643 patients.
Shin JY; Yoon JK; Diaz AZ
J Clin Neurosci; 2017 Mar; 37():34-39. PubMed ID: 28024733
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Adjuvant Radiation Therapy Alone and Chemotherapy Alone in Surgically Resected Low-Grade Gliomas: Survival Analyses of 2253 Cases from the National Cancer Data Base.
Wu J; Neale N; Huang Y; Bai HX; Li X; Zhang Z; Karakousis G; Huang R; Zhang PJ; Tang L; Xiao B; Yang L
World Neurosurg; 2018 Apr; 112():e812-e822. PubMed ID: 29409888
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of surgery and radiation therapy in cases of anaplastic astrocytoma: retrospective analysis of 170 cases.
Nomiya T; Nemoto K; Kumabe T; Takai Y; Yamada S
J Neurosurg; 2007 Apr; 106(4):575-81. PubMed ID: 17432706
[TBL] [Abstract][Full Text] [Related]
9. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
Gorlia T; Delattre JY; Brandes AA; Kros JM; Taphoorn MJ; Kouwenhoven MC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ
Eur J Cancer; 2013 Nov; 49(16):3477-85. PubMed ID: 23896377
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of predictors influencing the results of the combined treatment for anaplastic astrocytomas (grade III) of the brain].
Solodky VA; Panshin GA; Bychkov YM; Anashkina MV; Milyukov SM; Izmailov TR
Vopr Onkol; 2015; 61(1):25-30. PubMed ID: 26016141
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant temozolomide-based chemoradiotherapy versus radiotherapy alone in patients with WHO III astrocytoma: The Mainz experience.
Mayer A; Schwanbeck C; Sommer C; Stockinger M; Giese A; Renovanz M; Vaupel P; Schmidberger H
Strahlenther Onkol; 2015 Aug; 191(8):665-71. PubMed ID: 26025143
[TBL] [Abstract][Full Text] [Related]
12. Survival and prognostic factors of anaplastic gliomas.
Nuño M; Birch K; Mukherjee D; Sarmiento JM; Black KL; Patil CG
Neurosurgery; 2013 Sep; 73(3):458-65; quiz 465. PubMed ID: 23719055
[TBL] [Abstract][Full Text] [Related]
13. Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients.
Wahner HCW; Träger M; Bender K; Schweizer L; Onken J; Senger C; Ehret F; Budach V; Kaul D
Radiat Oncol; 2020 Dec; 15(1):282. PubMed ID: 33334378
[TBL] [Abstract][Full Text] [Related]
14. Sequencing of Chemotherapy and Radiotherapy for Newly Diagnosed Anaplastic Oligodendroglioma and Oligoastrocytoma.
Ryckman JM; Surkar SM; Haque W; Butler EB; Teh BS; Verma V
Am J Clin Oncol; 2019 Mar; 42(3):258-264. PubMed ID: 30601146
[TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
16. Presentation, management, and outcome of elderly patients with newly-diagnosed anaplastic astrocytoma.
Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF
J Neurooncol; 2012 Nov; 110(2):227-35. PubMed ID: 22875708
[TBL] [Abstract][Full Text] [Related]
17. The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide.
Strowd RE; Abuali I; Ye X; Lu Y; Grossman SA
J Neurooncol; 2016 Mar; 127(1):165-71. PubMed ID: 26729269
[TBL] [Abstract][Full Text] [Related]
18. Patterns of care and outcomes of multi-agent versus single-agent chemotherapy as part of multimodal management of low grade glioma.
Haque W; Verma V; Butler EB; Teh BS
J Neurooncol; 2017 Jun; 133(2):369-375. PubMed ID: 28432588
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of radiotherapy for elderly patients with anaplastic gliomas.
Mukherjee D; Sarmiento JM; Nosova K; Boakye M; Lad SP; Black KL; Nuño M; Patil CG
J Clin Neurosci; 2014 May; 21(5):773-8. PubMed ID: 24355207
[TBL] [Abstract][Full Text] [Related]
20. Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.
Noël G; Schott R; Froelich S; Gaub MP; Boyer P; Fischer-Lokou D; Dufour P; Kehrli P; Maitrot D
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):749-55. PubMed ID: 21300471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
